300497.SZ
富祥股份
SZSE · Healthcare · C 制造业 · CN
CNY 17.02
−1.45%Year over year
Reported trailing growth
- Revenue
- +22.2%
- EBITDA
- —
- EBIT
- +96.3%
- EPS
- +101.6%
- Free cash flow
- -39.7%
- Operating cash flow
- -71.8%
Forward estimates
Based on analyst estimates
- Revenue
- -59.8%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -10.4%
- EBITDA
- +206.9%
- EBIT
- +77.8%
- Net income
- +79.8%
- EPS
- +80.4%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026